• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

抑制 NADPH 氧化酶 4 可减轻乳腺癌中的淋巴管生成和肿瘤转移。

Inhibition of NADPH oxidase 4 attenuates lymphangiogenesis and tumor metastasis in breast cancer.

机构信息

Cheeloo College of Medicine, Shandong University, Jinan, People's Republic of China.

Breast Cancer Center, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, People's Republic of China.

出版信息

FASEB J. 2021 Apr;35(4):e21531. doi: 10.1096/fj.202002533R.

DOI:10.1096/fj.202002533R
PMID:33769605
Abstract

Lymphangiogenesis is thought to contribute to promote tumor cells to enter lymphatic vessels and plant at a secondary site. Endothelial cells are the cornerstone of the generation of new lymphatic vessels. NADPH oxidase 4 (Nox4) is the most abundant one of NADPH oxidases in endothelial cells and the most studied one in relevance with cancer. Our purpose is to analyze the relationship between Nox4 and lymphangiogenesis and find out whether the newborn lymphatic vessels lead to cancer metastasis. We first explored the expression of Nox4 in lymphatic endothelial cells of primary invasive breast tumors and human normal mammary glands using GEO databases and found that Nox4 was upregulated in primary invasive breast tumors samples. In addition, its high expression correlated with lymph node metastasis in breast cancer patients. Nox4 could increase the tube formation and lymphatic vessel sprouting in a three-dimensional setting. In vivo, inhibition of Nox4 in 4T1 tumor-bearing mice could significantly decrease the tumor lymphangiogenesis and metastasis. Nox4 may increase tumor lymphangiogenesis via ROS/ERK/CCL21 pathway and attract CCR7-positive breast cancer cells to entry lymphatic vessels and distant organs. In conclusion, our results show that Nox4 is a factor that promotes lymphangiogenesis and is a potential target of antitumor metastasis.

摘要

淋巴管生成被认为有助于促进肿瘤细胞进入淋巴管并在继发性部位定植。内皮细胞是新淋巴管生成的基石。NADPH 氧化酶 4(Nox4)是内皮细胞中 NADPH 氧化酶中最丰富的一种,也是与癌症相关性研究最多的一种。我们的目的是分析 Nox4 与淋巴管生成之间的关系,并探讨新生淋巴管是否导致癌症转移。我们首先使用 GEO 数据库探索了原发性浸润性乳腺癌和人正常乳腺淋巴管内皮细胞中 Nox4 的表达,发现 Nox4 在原发性浸润性乳腺癌样本中上调。此外,其高表达与乳腺癌患者的淋巴结转移相关。Nox4 可以在三维环境中增加管形成和淋巴管发芽。在体内,在 4T1 荷瘤小鼠中抑制 Nox4 可显著降低肿瘤淋巴管生成和转移。Nox4 可能通过 ROS/ERK/CCL21 途径增加肿瘤淋巴管生成,并吸引 CCR7 阳性乳腺癌细胞进入淋巴管和远处器官。总之,我们的结果表明 Nox4 是促进淋巴管生成的因素,是抗肿瘤转移的潜在靶点。

相似文献

1
Inhibition of NADPH oxidase 4 attenuates lymphangiogenesis and tumor metastasis in breast cancer.抑制 NADPH 氧化酶 4 可减轻乳腺癌中的淋巴管生成和肿瘤转移。
FASEB J. 2021 Apr;35(4):e21531. doi: 10.1096/fj.202002533R.
2
Extracellular Hsp90α Promotes Tumor Lymphangiogenesis and Lymph Node Metastasis in Breast Cancer.细胞外热休克蛋白 90α 促进乳腺癌淋巴管生成和淋巴结转移。
Int J Mol Sci. 2021 Jul 20;22(14):7747. doi: 10.3390/ijms22147747.
3
Targeting VEGFR-3/-2 signaling pathways with AD0157: a potential strategy against tumor-associated lymphangiogenesis and lymphatic metastases.用AD0157靶向VEGFR-3/-2信号通路:一种对抗肿瘤相关淋巴管生成和淋巴转移的潜在策略。
J Hematol Oncol. 2017 Jun 19;10(1):122. doi: 10.1186/s13045-017-0484-1.
4
Sunitinib inhibits lymphatic endothelial cell functions and lymph node metastasis in a breast cancer model through inhibition of vascular endothelial growth factor receptor 3.舒尼替尼通过抑制血管内皮生长因子受体 3 抑制乳腺癌模型中的淋巴管内皮细胞功能和淋巴结转移。
Breast Cancer Res. 2011 Jun 21;13(3):R66. doi: 10.1186/bcr2903.
5
S100A4-dependent glycolysis promotes lymphatic vessel sprouting in tumor.S100A4 依赖性糖酵解促进肿瘤淋巴管生成。
Angiogenesis. 2023 Feb;26(1):19-36. doi: 10.1007/s10456-022-09845-6. Epub 2022 Jul 12.
6
Lysyl Oxidase-Like Protein 2 Promotes Tumor Lymphangiogenesis and Lymph Node Metastasis in Breast Cancer.赖氨酰氧化酶样蛋白 2 促进乳腺癌肿瘤淋巴管生成和淋巴结转移。
Neoplasia. 2019 Apr;21(4):413-427. doi: 10.1016/j.neo.2019.03.003. Epub 2019 Mar 27.
7
The role of CCL21/CCR7 chemokine axis in breast cancer-induced lymphangiogenesis.CCL21/CCR7趋化因子轴在乳腺癌诱导的淋巴管生成中的作用。
Mol Cancer. 2015 Feb 10;14:35. doi: 10.1186/s12943-015-0306-4.
8
Inhibition of TGFBIp expression reduces lymphangiogenesis and tumor metastasis.抑制 TGFBIp 表达可减少淋巴管生成和肿瘤转移。
Oncogene. 2016 Jan 14;35(2):196-205. doi: 10.1038/onc.2015.73. Epub 2015 Mar 16.
9
Roles of prostaglandins in tumor-associated lymphangiogenesis with special reference to breast cancer.前列腺素在肿瘤相关淋巴管生成中的作用,特别参考乳腺癌。
Cancer Metastasis Rev. 2018 Sep;37(2-3):369-384. doi: 10.1007/s10555-018-9734-0.
10
Nectin-4 promotes lymphangiogenesis and lymphatic metastasis in breast cancer by regulating CXCR4-LYVE-1 axis.Nectin-4 通过调节 CXCR4-LYVE-1 轴促进乳腺癌淋巴管生成和淋巴转移。
Vascul Pharmacol. 2021 Oct;140:106865. doi: 10.1016/j.vph.2021.106865. Epub 2021 May 1.

引用本文的文献

1
Advances in the regulation of macrophage polarization by the tumor microenvironment.肿瘤微环境对巨噬细胞极化调控的研究进展
Discov Oncol. 2025 Aug 6;16(1):1487. doi: 10.1007/s12672-025-03258-9.
2
Mechanism insights and therapeutic intervention of tumor metastasis: latest developments and perspectives.肿瘤转移的机制洞察与治疗干预:最新进展与展望
Signal Transduct Target Ther. 2024 Aug 2;9(1):192. doi: 10.1038/s41392-024-01885-2.
3
Tumor-associated macrophages in anti-PD-1/PD-L1 immunotherapy for hepatocellular carcinoma: recent research progress.
肿瘤相关巨噬细胞在肝细胞癌抗PD-1/PD-L1免疫治疗中的研究进展
Front Pharmacol. 2024 Jun 18;15:1382256. doi: 10.3389/fphar.2024.1382256. eCollection 2024.
4
Lymphatic vessel: origin, heterogeneity, biological functions, and therapeutic targets.淋巴管:起源、异质性、生物学功能和治疗靶点。
Signal Transduct Target Ther. 2024 Jan 3;9(1):9. doi: 10.1038/s41392-023-01723-x.
5
NOX4-derived ROS Regulates Aerobic Glycolysis of Breast Cancer through YAP Pathway.NOX4衍生的活性氧通过YAP途径调节乳腺癌的有氧糖酵解。
J Cancer. 2023 Aug 21;14(13):2562-2573. doi: 10.7150/jca.81099. eCollection 2023.
6
Conjugated Bile Acids Promote Lymphangiogenesis by Modulation of the Reactive Oxygen Species-p90RSK-Vascular Endothelial Growth Factor Receptor 3 Pathway.结合胆汁酸通过调节活性氧物质-p90RSK-血管内皮生长因子受体 3 通路促进淋巴管生成。
Cells. 2023 Feb 6;12(4):526. doi: 10.3390/cells12040526.
7
Metabolic heterogeneity protects metastatic mucosal melanomas cells from ferroptosis.代谢异质性保护转移性黏膜黑色素瘤细胞免受铁死亡。
Int J Mol Med. 2022 Oct;50(4). doi: 10.3892/ijmm.2022.5180. Epub 2022 Aug 25.
8
LncRNA CASC9 activated by STAT3 promotes the invasion of breast cancer and the formation of lymphatic vessels by enhancing H3K27ac-activated SOX4.长链非编码 RNA CASC9 通过增强 STAT3 激活的 H3K27ac 促进 SOX4 的表达从而促进乳腺癌的侵袭和淋巴管生成。
Kaohsiung J Med Sci. 2022 Sep;38(9):848-857. doi: 10.1002/kjm2.12573. Epub 2022 Jul 21.
9
Upregulation of Nox4 induces a pro-survival Nrf2 response in cancer-associated fibroblasts that promotes tumorigenesis and metastasis, in part via Birc5 induction.Nox4 的上调诱导癌症相关成纤维细胞中一种促生存的 Nrf2 反应,促进肿瘤发生和转移,部分是通过 Birc5 的诱导。
Breast Cancer Res. 2022 Jul 14;24(1):48. doi: 10.1186/s13058-022-01548-6.
10
Reactive Oxygen Species in Regulating Lymphangiogenesis and Lymphatic Function.活性氧在调节淋巴管生成和淋巴管功能中的作用。
Cells. 2022 May 26;11(11):1750. doi: 10.3390/cells11111750.